Equities

GenMont Biotech Inc

3164:TAI

GenMont Biotech Inc

Actions
Consumer Staples Food Producers
  • Price (TWD)23.10
  • Today's Change0.300 / 1.32%
  • Shares traded43.45k
  • 1 Year change-0.43%
  • Beta--
Data delayed at least 20 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments328401422
Total Receivables, Net405255
Total Inventory885537
Prepaid expenses9.071367
Other current assets, total------
Total current assets466522581
Property, plant & equipment, net1,0601,1131,059
Goodwill, net------
Intangibles, net2.260.240.33
Long term investments722735
Note receivable - long term------
Other long term assets6.054.273.98
Total assets1,6531,6961,698
LIABILITIES
Accounts payable7.851411
Accrued expenses----27
Notes payable/short-term debt000
Current portion long-term debt/capital leases4.601.062.11
Other current liabilities, total13414599
Total current liabilities146161139
Total long term debt543331
Total debt583533
Deferred income tax1.591.961.54
Minority interest133146148
Other liabilities, total2.372.372.32
Total liabilities337344322
SHAREHOLDERS EQUITY
Common stock865864864
Additional paid-in capital377376376
Retained earnings (accumulated deficit)90118155
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(16)(5.58)(18)
Total equity1,3161,3511,376
Total liabilities & shareholders' equity1,6531,6961,698
Total common shares outstanding878686
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.